Research by Experis shows 66% of CIOs are increasing investments in AI, yet only 9% have fully integrated AI into their operations and strategy. Organizations face challenges moving from AI pilots to enterprise-wide adoption while balancing growing cybersecurity needs. The study highlights the need for strong governance, skilled talent, and technology foundations to scale AI securely and create lasting business value. As AI reshapes roles, new positions like automation architects and data ethicists are emerging to support this transformation.
CIOs accelerating AI investment face low full integration rates, with only 9% reporting complete adoption. For readers following the Technology sector, here is Pluang's market snapshot as of Nov 10, 2026 20:03 WIB: out of 150 priced US tech stocks, 40 rose and 101 fell. Notable movers include AXTI at USD 40.62 (-5.34%), CIFR at USD 6.48 (-4.85%), and ASX at USD 36.00 (+4.77%), with typical hold times ranging from 17 to 50 days and mixed buy-sell order activity.
project44 has partnered with Snowflake to enhance supply chain decision-making through Mo, an AI-powered supply chain analyst. Mo uses project44's extensive logistics data and Snowflake Cortex AI to provide accurate, consistent answers to complex sup...
H&R Block has launched the Emerald Advance Loan, a fixed-rate short-term loan up to $1,750 with a 35.90% APR, designed to help families cover year-end expenses without monthly payments. Borrowers repay the loan in full by March 31, 2027, with no impa...
Duke Robotics has entered a strategic collaboration with Greek security firm CRONOS to commercialize its Insulator Cleaning Drone (IC Drone) technology in Greece. This partnership leverages CRONOS's strong presence in Greece's critical infrastructure...
Alm. Brand A/S repurchased 1,369,397 shares between November 3 and 9, 2026, at an average price of DKK 17.46 per share. This is part of their announced buy-back program totaling up to DKK 593 million, aiming to reduce the number of outstanding shares...
Novartis has secured first place in the 2026 Access to Medicine Index, maintaining its lead since 2024 by excelling across all assessed technical areas, including governance, R&D, and product delivery. The company scored 3.86 out of 5 overall, with a...
